| Section | Status | CDF | Name |
| 08.01.05 | Formulary |  |
Atezolizumab Tecentriq® |
| 08.01.01 | Formulary | |
Bendamustine |
| 08.01.05 | Formulary | |
Bevacizumab Avastin® |
| 08.01.05 | Formulary | |
Bortezomib Velcade® |
| 08.01.05 | Formulary | |
Brentuximab vedotin Adcetris® |
| 08.01.05 | Formulary | |
Cetuximab Erbitux® |
| 08.01.05 | Formulary | |
Crizotinib Xalkori® |
| 08.01.02 | Formulary | |
Doxorubicin Caelyx® |
| 08.01.05 | Formulary | |
Eribulin Halaven® |
| 08.01.05 | Formulary | |
Everolimus Afinitor® |
| 08.01.05 | Formulary | |
Ibrutinib |
| 08.02.04 | Formulary | |
Lenalidomide |
| 08.02.04 | Formulary | |
Nivolumab Opdivo® |
| 08.03.04.01 | Formulary | |
Palbociclib Ibrance® |
| 08.01.03 | Formulary | |
Pemetrexed Alimta® |
| 08.03.04.01 | Formulary | |
Ribociclib Kisqali® |
| 08.01.05 | Formulary | |
Sorafenib Nexavar® |